Erratum: Alkaline phosphatase combined with γ-glutamyl transferase is an independent predictor of prognosis of hepatocellular carcinoma patients receiving programmed death-1 inhibitors

DOI: https://doi.org/10.3389/fimmu.2023.1177261

IF: 7.3

2023-03-08

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1115706.].

immunology

What problem does this paper attempt to address?

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2023.1281693

2023-09-27

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1169537.].
Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Lanlan Xiao,Xingqi Xu,Kaizhou Huang,Yalei Zhao,Lingjian Zhang,Lanjuan Li

DOI: https://doi.org/10.1155/2021/9875940

2021-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2019/3757149.].
Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Frontiers Production Office

DOI: https://doi.org/10.3389/fphar.2022.1092147

IF: 5.6

2022-11-22

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.973448.].

pharmacology & pharmacy
Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Xinyang Liu,Shukui Qin,Zhichao Wang,Jianming Xu,Jianping Xiong,Yuxian Bai,Zhehai Wang,Yan Yang,Guoping Sun,Liwei Wang,Leizhen Zheng,Nong Xu,Ying Cheng,Weijian Guo,Hao Yu,Tianshu Liu,Pagona Lagiou,Jin Li

DOI: https://doi.org/10.1186/s13045-017-0545-5

IF: 28.5

2017-01-01

Journal of Hematology & Oncology

Abstract:The original article [1] contains two errors in Table 2
Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib

Lei Zhang,Zhi-Ping Yan,Zhong-Heng Hou,Peng Huang,Min-Jie Yang,Shuai Zhang,Shen Zhang,Shao-Hua Zhang,Xiao-Li Zhu,Cai-Fang Ni,Qiang Li

DOI: https://doi.org/10.3389/fmolb.2021.727969

IF: 6.113

2021-08-30

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.624366.].

biochemistry & molecular biology
Corrigendum: Relationship between programmed death ligand 1 expression and other clinicopathological features in a large cohort of gastric cancer patients

Xinhua Chen,Huimin Zhang,Minghao Wang,Hao Liu,Yanfeng Hu,Tian Lin,Hao Chen,Mingli Zhao,Tao Chen,Guoxin Li,Jiang Yu,Liying Zhao

DOI: https://doi.org/10.3389/fimmu.2023.1235273

IF: 7.3

2023-06-15

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783695.].

immunology
Erratum: Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

DOI: https://doi.org/10.2147/JHC.S467902

2024-03-14

Abstract:[This corrects the article DOI: 10.2147/JHC.S444530.].
Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity

Hao Zheng,Wen-juan Zheng,Zhen-guang Wang,Yuan-ping Tao,Zhi-ping Huang,Le Yang,Liu Ouyang,Zhi-qing Duan,Yi-nuo Zhang,Bo-ning Chen,Dai-min Xiang,Gang Jin,Lu Fang,Fan Zhou,Bo Liang

DOI: https://doi.org/10.3389/fimmu.2022.1093403

IF: 7.3

2022-12-08

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.845193.].

immunology
Corrigendum: PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC

Xiao Wang,Chao Liang,Xin Yao,Ruo-Han Yang,Zhan-Sheng Zhang,Fan-Ye Liu,Wen-Qi Li,Shu-Hua Pei,Jing Ma,Song-Qiang Xie,Dong Fang

DOI: https://doi.org/10.3389/fphar.2021.724799

IF: 5.6

2021-07-15

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.577108.].

pharmacology & pharmacy
Erratum: Alkaline Phosphatase Controls Lineage Switching of Mesenchymal Stem Cells by Regulating the LRP6/GSK3β Complex in Hypophosphatasia: Erratum.

Wenjia Liu,Liqiang Zhang,Kun Xuan,Chenghu Hu,Liya Li,Yongjie Zhang,Fang Jin,Yan Jin

DOI: https://doi.org/10.7150/thno.103686

IF: 11.6

2024-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.27372.].
Corrigendum: Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study

Qi Zheng,Hanzhou Wang,Wei Hou,Ying Zhang

DOI: https://doi.org/10.3389/fcvm.2021.828274

IF: 3.6

2022-01-06

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.755191.].

cardiac & cardiovascular systems
Erratum: Atopy as an independent predictor for long-term patient and graft survival after kidney transplantation

DOI: https://doi.org/10.3389/fimmu.2023.1175484

IF: 7.3

2023-03-08

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.997364.].

immunology
Corrigendum: Association of preoperative NANOG-positive circulating tumor cell levels with recurrence of hepatocellular carcinoma

Yongrong Lei,Xishu Wang,Heng Sun,Yuna Fu,Yichen Tian,Ludi Yang,Jianhua Wang,Feng Xia

DOI: https://doi.org/10.3389/fonc.2024.1438731

2024-07-10

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.601668.].
High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum

Ming Cui,Lei You,Bang Zheng,Xinmei Huang,Qiaofei Liu,Jing Huang,Boju Pan,Xiaoyan Qiu,Quan Liao,Yupei Zhao

DOI: https://doi.org/10.7150/jca.32930

IF: 3.9

2021-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.39800.].
Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection

DOI: https://doi.org/10.3389/fimmu.2023.1183107

IF: 7.3

2023-03-21

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.899161.].

immunology
Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Junfeng Zhang,Wei Xue,Kai Xu,Liang Yi,Yu Guo,Tian Xie,Haipeng Tong,Bo Zhou,Shunan Wang,Qing Li,Heng Liu,Xiao Chen,Jingqin Fang,Weiguo Zhang

DOI: https://doi.org/10.7150/thno.92042

IF: 11.6

2023-11-17

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.44427.].
Erratum: Advances in RIPK1 kinase inhibitors

DOI: https://doi.org/10.3389/fphar.2022.1123234

IF: 5.6

2023-01-09

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.976435.].

pharmacology & pharmacy
Corrigendum to “Preoperative fibrinogen is associated with the clinical survival of primary liver cancer patients and promotes hepatoma metastasis via the PTEN/AKT/mTOR pathway” [Heliyon 9(6) (June 2023) e16696]

Xuemeng Qian,Jiajing Cai,Qi Qi,Jia Han,Xinfang Zhu,Rong Xia,Qi Zhang

DOI: https://doi.org/10.1016/j.heliyon.2023.e19952

IF: 3.776

2023-01-01

Heliyon

Abstract:In the original published version of this article, Figure 7b (FIB + AZD of SMMC 7721 cell group) and Figure 7c (FIB of BEL 7404 cell group) was uploaded incorrectly. The correct versions of Figures 7b and c can be found below. The authors apologize for the errors. Both the HTML and PDF versions of the article have been updated to correct the errors. Preoperative fibrinogen is associated with the clinical survival of primary liver cancer patients and promotes hepatoma metastasis via the PTEN/AKT/mTOR pathwayQian et al.HeliyonMay 25, 2023In BriefHyperfibrinogenemia had been widely observed in various cancer patients, however, whether fibrinogen (FIB) influences the survival outcome of patients with primary liver cancer (PLC) remains unknown. This study was aimed to evaluate the predictive value of preoperative FIB in the survival outcome of PLC patients and explore the possible mechanism. Full-Text PDF Open Access
Erratum: Approaching hemophagocytic lymphohistiocytosis

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1369687

IF: 7.3

2024-01-22

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1210041.].

immunology

Erratum: Alkaline phosphatase combined with γ-glutamyl transferase is an independent predictor of prognosis of hepatocellular carcinoma patients receiving programmed death-1 inhibitors

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib

Corrigendum: Relationship between programmed death ligand 1 expression and other clinicopathological features in a large cohort of gastric cancer patients

Erratum: Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity

Corrigendum: PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC

Erratum: Alkaline Phosphatase Controls Lineage Switching of Mesenchymal Stem Cells by Regulating the LRP6/GSK3β Complex in Hypophosphatasia: Erratum.

Corrigendum: Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study

Erratum: Atopy as an independent predictor for long-term patient and graft survival after kidney transplantation

Corrigendum: Association of preoperative NANOG-positive circulating tumor cell levels with recurrence of hepatocellular carcinoma

High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum

Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection

Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Erratum: Advances in RIPK1 kinase inhibitors

Corrigendum to “Preoperative fibrinogen is associated with the clinical survival of primary liver cancer patients and promotes hepatoma metastasis via the PTEN/AKT/mTOR pathway” [Heliyon 9(6) (June 2023) e16696]

Erratum: Approaching hemophagocytic lymphohistiocytosis